{"@id":"https://bioecon.ru/technology/urine-biomarker-risk-scores/","@type":"Technology","cluster":"diagnostics-medtech","formats":{"html":"https://en.bioecon.ru/technology/urine-biomarker-risk-scores/","json":"https://en.bioecon.ru/api/v1/technology/urine-biomarker-risk-scores/index.json"},"id":"urine-biomarker-risk-scores","industries":["diagnostics","medtech-devices","pharma"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/diagnostics/","https://bioecon.ru/industries/medtech-devices/","https://bioecon.ru/industries/pharma/"],"suppliers":["https://bioecon.ru/companies/euphoria-retreat/","https://bioecon.ru/companies/acadian-plant-health/","https://bioecon.ru/companies/eleta/","https://bioecon.ru/companies/boston-scientific/","https://bioecon.ru/companies/schr-dinger/","https://bioecon.ru/companies/naturemetrics/","https://bioecon.ru/companies/charm-industrial/","https://bioecon.ru/companies/hedley-technologies-ltd/","https://bioecon.ru/companies/hercon-environmental/","https://bioecon.ru/companies/metso/"]},"maturity":8,"name":"Urine Biomarker Risk Scores","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Urine specimen stabilization and pre-processing"},{"n":2,"title":"Multiplex ELISA and RT-qPCR quantification"},{"n":3,"title":"Algorithmic risk score computation"},{"n":4,"title":"Clinical utility and biopsy avoidance validation"}],"summary":"Multiplex quantitative biomarker quantification in non-invasive urine and post-DRE specimens coupled with machine learning multivariate risk algorithms, ruling out unnecessary prostate biopsies and classifying aggressive urological malignancies.","url":"/technology/urine-biomarker-risk-scores/","verified":"2026-11-22"}